Dr. Barnum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
617 Bienville St.
Suite A
Natchitoches, LA 71457Phone+1 318-352-9880Fax+1 318-357-1347
Summary
- Otis Barnum, DO, is an internal medicine specialist based in Natchitoches, LA. He completed his residency in internal medicine at Tulane University and his internship at the US Public Health Service Hospital. He graduated from Kansas City University of Medicine and Biosciences College of Osteopathic Medicine in 1977. He serves as Principal Investigator at Barnum Medical Research, Inc since 2009. Dr. Barnum is experienced in procedures such as esophagogastroduodenoscopy, colonoscopy, and foreign body removal, as well as clinical research and trials. His research includes publications on type 2 diabetes, influenza, cardiovascular outcomes, and atherosclerotic events, with works featured in journals such as Diabetes Care and The New England Journal of Medicine. He is recognized as a Fellow of the American College of Physicians.
Clinical Expertise
- Esophagogastroduodenoscopy, Colonoscopy, Foreign body removal, Clinical research, Clincial trials
Education & Training
- Tulane UniversityResidency, Internal Medicine, 1978 - 1981
- US Public Health Service HospitalInternship, Transitional Year, 1977 - 1978
- Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1977
Certifications & Licensure
- LA State License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow American College of Physicians ACP
Publications & Presentations
PubMed
- 8 citationsEfficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.Suzana Margareth Lobo, Gaétan Plantefève, Girish Nair, Adilson Joaquim Cavalcante, Nara Franzin de Moraes
Eclinicalmedicine. 2024-02-01 - 21 citationsEfficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalize...Anuradha Madan, Shuguang Chen, Phillip J. Yates, Michael L Washburn, G B Roberts
Open Forum Infectious Diseases. 2019-04-01 - Pathology case of the month. 41-year-old woman with abdominal discomfort and weight loss.Greg Wellman, Enrique Gonzalez, Diana M Veillon, Otis Barnum, James D. Cotelingam
The Journal of the Louisiana State Medical Society. 2004-07-01
Journal Articles
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: